Loading
Latest filing published 14 Feb 2023 for Comera Life Sciences Holdings, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
James Sherblom is a declared insider of Comera Life Sciences Holdings, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 12 September 2022 and the latest from 4 January 2023.
Purchases make up the whole of the open-market record (2 purchases). The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. In 2023 alone, the filings show 1 purchase and no sales.
Most recently, on 14 February 2023, the filings show an open-market purchase in Comera Life Sciences Holdings, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations